Emergent Biosolutions has deal to buy Narcan maker for up to $735M

A Maryland life sciences company with a focus on public health threats has plans to buy the maker of a nasal spray used to treat people suspected of overdosing on opioids.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.